Bromocriptine Mesylate and Triple Therapy
Determining the interaction of Bromocriptine Mesylate and Triple Therapy and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using bromocriptine together with clarithromycin may increase the effects of bromocriptine. Contact your doctor if you experience nausea, vomiting, constipation, sweating, pale skin, dizziness, drowsiness, yawning, confusion, hallucinations, muscle movements you cannot control, or loss of balance or coordination. If your doctor does prescribe these medications together, you may need a dose adjustment or special test to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Certain macrolide antibiotics may decrease the hepatic metabolism of bromocriptine. The proposed mechanism of the interaction is inhibition of CYP450 3A4. High bromocriptine plasma levels have been associated with dyskinesia, particularly in the elderly receiving bromocriptine for the treatment of symptoms of Parkinson's disease.
MANAGEMENT: Patients should be monitored for signs of toxicity, including headache, hypotension, nausea, and dyskinesia. A reduction in bromocriptine dosage may be necessary. Some authorities suggest that the bromocriptine dose may need to be reduced by up to 50% in order to avoid toxicity. Although clinical data are lacking, some manufacturers advise that when high bromocriptine levels are observed consideration should be given to the increased risk of dyskinesia.
- Periti P, Mazzei T, Mini E, Novelli A "Pharmacokinetic drug interactions of macrolides." Clin Pharmacokinet 23 (1992): 106-31
- von Rosenstiel NA, Adam D "Macrolide antibacterials. Drug interactions of clinical significance." Drug Saf 13 (1995): 105-22
- "Product Information. Parlodel (bromocriptine)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
- Nelson MV, Berchou RC, Kareti D, Le Witt PA "Pharmacokinetic evaluation of erythromycin and caffeine administered with bromocriptine." Clin Pharmacol Ther 47 (1990): 694-7
Generic Name: bromocriptine
Brand name: Parlodel, Cycloset
Synonyms: Bromocriptine
Generic Name: amoxicillin / clarithromycin / lansoprazole
Brand name: Prevpac
Synonyms: Amoxicillin, clarithromycin, and lansoprazole, Lansoprazole, Amoxicillin, and Clarithromycin
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Bromocriptine Mesylate-Triple Vitamin Drops With Fluoride
- Bromocriptine Mesylate-Triplex DM
- Bromocriptine Mesylate-Tripohist
- Bromocriptine Mesylate-Triprolidine
- Bromocriptine Mesylate-Triprolidine and Phenylephrine Syrup
- Bromocriptine Mesylate-Triprolidine and Pseudoephedrine Liquid
- Triple Therapy-Brompheniramine
- Triple Therapy-Brompheniramine and codeine
- Triple Therapy-Brompheniramine and phenylephrine
- Triple Therapy-Brompheniramine and Phenylephrine Chewable Tablets
- Triple Therapy-Brompheniramine and Phenylephrine Liquid
- Triple Therapy-Brompheniramine and Phenylephrine Suspension